Article Versions Notes

Palleschi M, Maltoni R, Ravaioli S, Vagheggini A, Mannozzi F, Fanini F, Pirini F, Tumedei MM, Barzotti E, Cecconetto L, et al. Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics. 2020; 10(8):573. https://doi.org/10.3390/diagnostics10080573

Palleschi, Michela, Roberta Maltoni, Sara Ravaioli, Alessandro Vagheggini, Francesca Mannozzi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei, Eleonora Barzotti, Lorenzo Cecconetto, and et al. 2020. "Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience" Diagnostics 10, no. 8: 573. https://doi.org/10.3390/diagnostics10080573

Palleschi, M., Maltoni, R., Ravaioli, S., Vagheggini, A., Mannozzi, F., Fanini, F., Pirini, F., Tumedei, M. M., Barzotti, E., Cecconetto, L., Sarti, S., Manunta, S., Possanzini, P., Fedeli, A., Curcio, A., Altini, M., De Giorgi, U., Rocca, A., & Bravaccini, S. (2020). Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics, 10(8), 573. https://doi.org/10.3390/diagnostics10080573